Literature DB >> 36279002

Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial.

João Pedro Ferreira1,2,3, John G F Cleland4, Nicolas Girerd5, Pierpaolo Pellicori4, Mark R Hazebroek6, Job Verdonschot7, Timothy J Collier8, Johannes Petutschnigg9, Andrew L Clark10, Jan A Staessen11, Stephane Heymans6, Faiez Zannad5, Patrick Rossignol5.   

Abstract

Entities:  

Year:  2022        PMID： 36279002     DOI： 10.1007/s00392-022-02116-w

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   6.138


× No keyword cloud information.
  10 in total

1.  Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.

Authors:  Tariq Ahmad; Keyanna Jackson; Veena S Rao; W H Wilson Tang; Meredith A Brisco-Bacik; Horng H Chen; G Michael Felker; Adrian F Hernandez; Christopher M O'Connor; Venkata S Sabbisetti; Joseph V Bonventre; F Perry Wilson; Steven G Coca; Jeffrey M Testani
Journal:  Circulation       Date:  2018-01-19       Impact factor: 29.690

2.  Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.

Authors:  Iris E Beldhuis; Peder L Myhre; Michael Bristow; Brian Claggett; Kevin Damman; James C Fang; Jerome L Fleg; Sonja McKinlay; Eldrin F Lewis; Eileen O'Meara; Bertram Pitt; Sanjiv J Shah; Orly Vardeny; Adriaan A Voors; Marc A Pfeffer; Scott D Solomon; Akshay S Desai
Journal:  J Am Coll Cardiol       Date:  2021-03-09       Impact factor: 24.094

Review 3.  Heart failure drug treatment.

Authors:  Patrick Rossignol; Adrian F Hernandez; Scott D Solomon; Faiez Zannad
Journal:  Lancet       Date:  2019-03-09       Impact factor: 79.321

4.  Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.

Authors:  Luca Monzo; João Pedro Ferreira; John G F Cleland; Pierpaolo Pellicori; Beatrice Mariottoni; Mark R Hazebroek; Tim J Collier; Joe J Cuthbert; Burkert Pieske; Johannes Petutschnigg; Fozia Z Ahmed; Nicolas Girerd; Andrew L Clark; Franco Cosmi; Jan A Staessen; Stephane Heymans; Patrick Rossignol; Faiez Zannad
Journal:  ESC Heart Fail       Date:  2022-09-06

5.  Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

Authors:  Patrick Rossignol; Daniela Dobre; John J V McMurray; Karl Swedberg; Henry Krum; Dirk J van Veldhuisen; Harry Shi; Michael Messig; John Vincent; Nicolas Girerd; George Bakris; Bertram Pitt; Faiez Zannad
Journal:  Circ Heart Fail       Date:  2013-12-02       Impact factor: 8.790

6.  Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).

Authors:  Orly Vardeny; Dong Hong Wu; Akshay Desai; Patrick Rossignol; Faiez Zannad; Bertram Pitt; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2012-10-17       Impact factor: 24.094

7.  Impact of Geographic Region on the COMMANDER-HF Trial.

Authors:  João Pedro Ferreira; John G F Cleland; Carolyn S P Lam; Dirk J van Veldhuisen; William M Byra; David A La Police; Stefan D Anker; Mandeep R Mehra; Céline Leroy; Valerie Eschwege; Marie Toussaint-Hacquard; Patrick Rossignol; Barry Greenberg; Faiez Zannad
Journal:  JACC Heart Fail       Date:  2021-02-03       Impact factor: 12.035

Review 8.  Ultrasound imaging of congestion in heart failure: examinations beyond the heart.

Authors:  Pierpaolo Pellicori; Elke Platz; Jeroen Dauw; Jozine M Ter Maaten; Pieter Martens; Emanuele Pivetta; John G F Cleland; John J V McMurray; Wilfried Mullens; Scott D Solomon; Faiez Zannad; Luna Gargani; Nicolas Girerd
Journal:  Eur J Heart Fail       Date:  2020-11-23       Impact factor: 15.534

9.  Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial.

Authors:  João Pedro Ferreira; Patrick Rossignol; George Bakris; Cyrus Mehta; William B White; Faiez Zannad
Journal:  Am J Nephrol       Date:  2021-12-06       Impact factor: 3.754

10.  Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Stefan D Anker; Javed Butler; Muhammad Shahzeb Khan; William T Abraham; Johann Bauersachs; Edimar Bocchi; Biykem Bozkurt; Eugene Braunwald; Vijay K Chopra; John G Cleland; Justin Ezekowitz; Gerasimos Filippatos; Tim Friede; Adrian F Hernandez; Carolyn S P Lam; JoAnn Lindenfeld; John J V McMurray; Mandeep Mehra; Marco Metra; Milton Packer; Burkert Pieske; Stuart J Pocock; Piotr Ponikowski; Giuseppe M C Rosano; John R Teerlink; Hiroyuki Tsutsui; Dirk J Van Veldhuisen; Subodh Verma; Adriaan A Voors; Janet Wittes; Faiez Zannad; Jian Zhang; Petar Seferovic; Andrew J S Coats
Journal:  Eur Heart J       Date:  2020-06-07       Impact factor: 29.983
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.